Literature DB >> 32817336

Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Tina Y Liu1, Jennifer A Doudna2,3,4,5,6,7,8.   

Abstract

Among the multiple antiviral defense mechanisms found in prokaryotes, CRISPR-Cas systems stand out as the only known RNA-programmed pathways for detecting and destroying bacteriophages and plasmids. Class 1 CRISPR-Cas systems, the most widespread and diverse of these adaptive immune systems, use an RNA-guided multiprotein complex to find foreign nucleic acids and trigger their destruction. In this review, we describe how these multisubunit complexes target and cleave DNA and RNA and how regulatory molecules control their activities. We also highlight similarities to and differences from Class 2 CRISPR-Cas systems, which use a single-protein effector, as well as other types of bacterial and eukaryotic immune systems. We summarize current applications of the Class 1 CRISPR-Cas systems for DNA/RNA modification, control of gene expression, and nucleic acid detection.

Keywords:  CRISPR-Cas; DNA endonuclease; archaea; bacteria; bacteriophage; crRNA; cyclic nucleotide; enzyme mechanism; gene regulation; genome editing; prokaryotic adaptive immunity; ribonuclease

Year:  2020        PMID: 32817336      PMCID: PMC7573268          DOI: 10.1074/jbc.REV120.007034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  134 in total

1.  A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.

Authors:  Saifu Pan; Qi Li; Ling Deng; Suping Jiang; Xuexia Jin; Nan Peng; Yunxiang Liang; Qunxin She; Yingjun Li
Journal:  RNA Biol       Date:  2019-05-26       Impact factor: 4.652

2.  Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.

Authors:  Patrick Pausch; Hanna Müller-Esparza; Daniel Gleditzsch; Florian Altegoer; Lennart Randau; Gert Bange
Journal:  Mol Cell       Date:  2017-08-03       Impact factor: 17.970

3.  A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.

Authors:  Wenyuan Han; Stefano Stella; Yan Zhang; Tong Guo; Karolina Sulek; Li Peng-Lundgren; Guillermo Montoya; Qunxin She
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

4.  The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system.

Authors:  Juliane Behler; Kundan Sharma; Viktoria Reimann; Annegret Wilde; Henning Urlaub; Wolfgang R Hess
Journal:  Nat Microbiol       Date:  2018-02-05       Impact factor: 17.745

Review 5.  A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

Authors:  Ryan N Jackson; Blake Wiedenheft
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

6.  In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target.

Authors:  Sabin Mulepati; Scott Bailey
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

7.  The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.

Authors:  Kawanda Foster; Joshua Kalter; Walter Woodside; Rebecca M Terns; Michael P Terns
Journal:  RNA Biol       Date:  2018-08-01       Impact factor: 4.652

8.  Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression.

Authors:  Michelle L Luo; Adam S Mullis; Ryan T Leenay; Chase L Beisel
Journal:  Nucleic Acids Res       Date:  2014-10-17       Impact factor: 16.971

9.  Comprehensive search for accessory proteins encoded with archaeal and bacterial type III CRISPR-cas gene cassettes reveals 39 new cas gene families.

Authors:  Shiraz A Shah; Omer S Alkhnbashi; Juliane Behler; Wenyuan Han; Qunxin She; Wolfgang R Hess; Roger A Garrett; Rolf Backofen
Journal:  RNA Biol       Date:  2018-06-19       Impact factor: 4.652

10.  Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems.

Authors:  David Burstein; Christine L Sun; Christopher T Brown; Itai Sharon; Karthik Anantharaman; Alexander J Probst; Brian C Thomas; Jillian F Banfield
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919

View more
  14 in total

Review 1.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 2.  Toward a next-generation diagnostic tool: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses.

Authors:  Md Mamunul Islam; Dipak Koirala
Journal:  Anal Chim Acta       Date:  2021-12-01       Impact factor: 6.911

Review 3.  Recent advances in CRISPR technologies for genome editing.

Authors:  Myeonghoon Song; Taeyoung Koo
Journal:  Arch Pharm Res       Date:  2021-06-23       Impact factor: 4.946

Review 4.  Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.

Authors:  Narmadhaa Siva; Sonal Gupta; Ayam Gupta; Jayendra Nath Shukla; Babita Malik; Nidhi Shukla
Journal:  3 Biotech       Date:  2021-02-26       Impact factor: 2.406

5.  Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems.

Authors:  Renke Tan; Ryan K Krueger; Max J Gramelspacher; Xufei Zhou; Yibei Xiao; Ailong Ke; Zhonggang Hou; Yan Zhang
Journal:  Mol Cell       Date:  2022-01-19       Impact factor: 17.970

Review 6.  CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19.

Authors:  Saeedeh Ebrahimi; Hashem Khanbabaei; Samaneh Abbasi; Mona Fani; Saber Soltani; Milad Zandi; Zahra Najafimemar
Journal:  Avicenna J Med Biotechnol       Date:  2022 Jan-Mar

Review 7.  The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.

Authors:  Sydney Newsom; Hari Priya Parameshwaran; Lindsie Martin; Rakhi Rajan
Journal:  Front Cell Infect Microbiol       Date:  2021-01-28       Impact factor: 5.293

8.  Accelerated RNA detection using tandem CRISPR nucleases.

Authors:  Tina Y Liu; Gavin J Knott; Dylan C J Smock; John J Desmarais; Sungmin Son; Abdul Bhuiya; Shrutee Jakhanwal; Noam Prywes; Shreeya Agrawal; María Díaz de León Derby; Neil A Switz; Maxim Armstrong; Andrew R Harris; Emeric J Charles; Brittney W Thornton; Parinaz Fozouni; Jeffrey Shu; Stephanie I Stephens; G Renuka Kumar; Chunyu Zhao; Amanda Mok; Anthony T Iavarone; Arturo M Escajeda; Roger McIntosh; Shin E Kim; Eli J Dugan; Katherine S Pollard; Ming X Tan; Melanie Ott; Daniel A Fletcher; Liana F Lareau; Patrick D Hsu; David F Savage; Jennifer A Doudna
Journal:  medRxiv       Date:  2021-03-24

Review 9.  An Outlook on Global Regulatory Landscape for Genome-Edited Crops.

Authors:  Aftab Ahmad; Nayla Munawar; Zulqurnain Khan; Alaa T Qusmani; Sultan Habibullah Khan; Amer Jamil; Sidra Ashraf; Muhammad Zubair Ghouri; Sabin Aslam; Muhammad Salman Mubarik; Ahmad Munir; Qaiser Sultan; Kamel A Abd-Elsalam; Sameer H Qari
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

Review 10.  Digging into the lesser-known aspects of CRISPR biology.

Authors:  Noemí M Guzmán; Belén Esquerra-Ruvira; Francisco J M Mojica
Journal:  Int Microbiol       Date:  2021-09-06       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.